Preliminary Program subject to change
18J01 Technology Roadmap: Pharmaceutical Product Development & Manufacturing I
OverviewThe FDA Critical Path Initiative has identified the lack of innovative technology in pharmaceutical product development and manufacture to be a major impediment to reducing time to market as well as cost of drugs. In response to this Initiative, the National Institute for Pharamceutical Technology & Education, a non-for-profit organization, in cooperation with ISPE and the FDA has undertaken development of a Technology Roadmap which identifies specific research needs in these technology domains. In this session two of the main areas of the draft roadmap ( pharmaceutical materials and product development) will be reviewed and feedback sollicited from the ChE research community.
Primary SponsorResearch and New Technology Committee (18j)

Chair

Gintaras V. Reklaitis
Professor
Purdue University, School of Chemical Engineering
1283 Chemical Engineering Building
West Lafayette, IN 47907
Phone Number: 1-765-494-4075
Fax Number: 1-765-494-0805
Email: reklaiti@ecn.purdue.edu

CoChair

Michael Pikal
Professor of Pharmaceutics
Pharmacy
University of Connecticut
69 North Eagleville Road
Unit 3092
Storrs, CT 06269-3092
Phone Number: 1-860-486-3202
Email: michael.pikal@uconn.edu
Technology Roadmap: Context and Drivers for Roadmap Development
Prabir K. Basu, National Institute for Pharmaceutical Technology and Education, Purdue University, 315 Hovde Hall, 610 Purdue Mall, West Lafayette, IN 47907
Technology Roadmap: Pharmaceutical Materials Component
Michael Pikal, Pharmacy, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269-3092
Panel Discussion
Technology Roadmap: Product Development Component
Lee E. Kirsch, Divsion of Pharmaceutics, University of Iowa, Pharmacy Building, PHAR S221, Iowa City, IA 52242
Discussion

Liaison Functions